Intervention Protocol

You have free access to this content

Probiotics for vulvovaginal candidiasis in non-pregnant women

  1. Huan Yu Xie1,
  2. Dan Feng2,
  3. Dong Mei Wei2,
  4. Hui Chen2,
  5. Ling Mei2,
  6. Xun Wang2,
  7. Fang Fang2,*

Editorial Group: Cochrane STI Group

Published Online: 30 APR 2013

DOI: 10.1002/14651858.CD010496


How to Cite

Xie HY, Feng D, Wei DM, Chen H, Mei L, Wang X, Fang F. Probiotics for vulvovaginal candidiasis in non-pregnant women (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD010496. DOI: 10.1002/14651858.CD010496.

Author Information

  1. 1

    People's Hospital of Deyang City, Department of Obstetrics and Gynecology, Deyang, Sichuan, China

  2. 2

    West China Second University Hospital, West China Women's and Children's Hospital, Department of Obstetrics and Gynecology, Chengdu, Sichuan, China

*Fang Fang, Department of Obstetrics and Gynecology, West China Second University Hospital, West China Women's and Children's Hospital, No. 17, Section Three, Ren Min Nan Lu Avenue, Chengdu, Sichuan, 610041, China. fangf59@yahoo.com.cn.

Publication History

  1. Publication Status: New
  2. Published Online: 30 APR 2013

SEARCH

References

Additional references

Anderson 2004
Andreu 2004
Beigi 2004
Bertholf 1983
Bieber 2006
  • Bieber EJ, Sanfilippo JS, Horowitz IR, et al. Clinical Gynecology. Philadelphia: Churchill Livingstone, 2006.
Centers 2010
  • Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines. MMWR 2010;59(RR-12):61-3.
Cochrane Handbook
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. available from www.cochrane-handbook.org.
Doron 2006
  • Doron S,  Gorbach SL. Probiotics: their role in the treatment and prevention of disease. Expert Review of Anti-Infective Therapy 2006;4(2):261-75.
Eckert 1998
  • Eckert LO,  Hawes SE,  Stevens CE,  Koutsky LA,  Eschenbach DA,  Holmes KK. Vulvovaginal candidiasis: clinical manifestations,risk factors, management algorithm. Obstetrics and Gynecology 1998;92:757-65.
Falagas 2006
Faro 1994
  • Faro S. Systemic vs. topical therapy for the treatment of vulvovaginal candidiasis. Infectious Diseases in Obstetrics and Gynecology 1994;1(4):202-8.
Faro1997
  • Faro S, Apuzzio J, Bohannon N, Elliott K, Martens M, Mou S, Phillips Lou, et al. Treatment Considerations in Vulvovaginal Candidiasis. The Female Patient 1997;22:1-10.
Foxman 1998
  • Foxman B, Marsh JV, Gillespie B, Sobel JD. Frequency and response to vaginal symptoms among white and African American women: results of a random digit dialing survey. Journal of Womens Health 1998;7:1167-74.
Foxman 2000
Geiger 1995
Giraldo 2007
  • Giraldo PC, Babula O, Gonçalves AK, Linhares IM, Amaral RL, Ledger WJ, et al. Mannose-binding lectin gene polymorphism, vulvovaginal candidiasis, and bacterial vaginosis. Obstetrics and Gynecology 2007;109(5):1123-8.
Hettiarachchi 2010
Hillier 1997
  • Hillier SL,  Lau RJ. Vaginal microflora in postmenopausal women who have not received estrogen replacement therapy. Clinical Infectious Diseases 1997;25(Suppl 2):S123-6.
Ilkit 2011
Jeavons 2003
Kledanoff 1991
  • Kledanoff SJ, Hillier SL, Eschenbach DA, Waltersdorph AM. Control of the microbial flora of the vagina by H2O2 generating lactobacilli. The Journal of Infectious Diseases 1991;164(1):94-100.
Kopp-Hoolihan 2001
Lefebvre 2008
  • Lefebvre C, Eisinga A, McDonald S, Paul N. Enhancing access to reports of clinical trials published world-wide - the contribution of EMBASE records to the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library. Emerging Themes in Epidemiology 2008;5:13. [DOI: 10.1186/1742-7622-5-13]
Mahmoudi 2011
  • Mahmoudi Rad M, Zafarghandi S, Abbasabadi B, Tavallaee M. The epidemiology of Candida species associated with vulvovaginal candidiasis in an Iranian patient population. European Journal of Obstetrics, Gynecology, and Reproductive Biology 2011;155(2):199-203.
Martinez 2009a
Martinez 2009b
Mylonas 2011
Nurbhai 2007
Nyirjesy 2003
Nyirjesy 2008
Omar 2001
  • Omar AA. Gram stain versus culture in the diagnosis of vulvovaginal candidiasis. Eastern Mediterranean Health Journal 2001;7(6):925-34.
Othman 2007
Pappas 2009
  • Pappas PG,  Kauffman CA,  Andes D,  Benjamin DK Jr,  Calandra TF,  Edwards JE Jr, et al. Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clinical Infectious Diseases 2009;48(5):503-35.
Parmar 1998
Pirotta 2004
  • Pirotta M, Gunn J, Chondros P, Grover S, O'Malley P, Hurley S, et al. Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomized controlled trial. BMJ 2004;329:548-52.
Redondo-Lopez 1990
Reid 2001
Reid 2003a
Reid 2003b
Reid 2003c
  • Reid G, Charbonneau D, Erb J, Kochanowski B, BeuermanD, Poehner R, et al. Oral use of Lactobacillus rhamnosusGR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy women. FEMS Immunology and Medical Microbiology 2003;35(2):131-4.
Reid 2004
  • Reid G, Burton J, Devillard E. The rationale for probiotics in female urogenital healthcare. Medscape General Medicine 2004;6(1):49.
Reid 2005
  • G Reid, JA Hammond. Probiotics: Some evidence of their effectiveness. Canadian Family Physician 2005;51(11):1487-93.
Ross 1995
Sanders 2008
Sanglard 2002
Santosa 2006
Schaaf 1990
Senok 2005
Sobel 1998
  • Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology 1998;178(2):203-11.
Sobel 2007
Soll 1989
  • Soll DR, Galask R, Isley S, Rao TV, Stone D, Hicks J, et al. Switching of Candida albicans during successive episodes of recurrent vaginitis. Journal of Clinical Microbiology 1989;27(4):681-90.
Spinillo 1994
  • Spinillo A, Nicola S, Colonna L, Marangoni E, Cavanna C, Michelone G. Frequency and significance of drug resistance in vulvovaginal candidiasis. Gynecologic and Obstetric Investigation 1994;38(2):130-3.
Trama 2005
  • Trama JP, Adelson ME, Raphaelli I, Stemmer SM, Mordechai E. Detection of Candida species in vaginal samples in a clinical laboratory setting. Infectious Diseases in Obstetrics and Gynecology 2005;13(2):63-7.
Van Kessel 2003
  • Van Kessel K, Assefi N, Marrazzo J, Eckert L. Common complementary and alternative therapies for yeast vaginitis and bacterial vaginosis: a systematic review. Obstetrical & Gynecological Survey 2003;58(5):351-8.
Vanderhoof 2008
Watson 2007
Zhang 2008
  • Zhang HY, Lv X, Li Y. Safety and clinical use of microecological preparations. Adverse Drug Reactions Journal 2008;10(5):340-5.